🇺🇸 FDA

Company profile · Sponsor

Haleon

E32E65F · EMA pharma GB
Pipeline
3
Drugs
0
Patents
0

Quick answer

Haleon (E32E65F) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E32E65F
Exchange EMA
Company type pharma
Headquarters GB

Frequently asked questions

What is Haleon?

Haleon (E32E65F) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Haleon sponsor?

We track 3 ClinicalTrials.gov-linked programs for Haleon, including A Phase I, Randomised, Open Label, Single Center, Single Oral Dose, Three Treatment, Three Period, Three Sequence, Change-over Bioequivalence Study of Paracetamol Orodispersible Tablet 500 mg (Haleon) to assess Bioequivalence with Alvedon 500 mg Film-Coated Tablet (Haleon, Sweden) and Panadol 500 mg Film-Coated Tablet (Haleon, Australia) in Healthy Adult Subjects Under Fasting Conditions and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Haleon company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.